Galectin Therapeutics GALT
NASDAQ GALT
$3.29 -0.09 (-2.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Galectin Therapeutics (GALT) Capital Expenditures (2009 - 2014)

Updated

Galectin Therapeutics (GALT) recorded Capital Expenditures of $3,000 in Q4 2012.

Analysis

Galectin Therapeutics (GALT) Capital Expenditures (2009 - 2014) Analysis & Trends

For FY2012, Galectin Therapeutics reported Capital Expenditures of $5,000, unchanged from FY2011.

  • Across earlier years, Capital Expenditures came in at $5,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Galectin Therapeutics 224.13 Mn 167.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -431,000.00
Dec 31, 2013 431,000.00
Sep 30, 2013 -431,000.00
Jun 30, 2013 -431,000.00
Mar 31, 2013 -431,000.00
Dec 31, 2012 3,000.00
Sep 30, 2012 428,000.00
Jun 30, 2012 -426,000.00
Mar 31, 2012 -426,000.00
Sep 30, 2011 426,000.00
Jun 30, 2011 -421,000.00
Mar 31, 2011 -421,000.00
Mar 31, 2010 -421,000.00
Mar 31, 2009 -421,000.00
API Access

Galectin Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GALT&period=max&api_key=YOUR_API_KEY